DE69631132D1 - Orale arzneimittel zubereitung von piperdinoalkanole in gelöster form - Google Patents

Orale arzneimittel zubereitung von piperdinoalkanole in gelöster form

Info

Publication number
DE69631132D1
DE69631132D1 DE69631132T DE69631132T DE69631132D1 DE 69631132 D1 DE69631132 D1 DE 69631132D1 DE 69631132 T DE69631132 T DE 69631132T DE 69631132 T DE69631132 T DE 69631132T DE 69631132 D1 DE69631132 D1 DE 69631132D1
Authority
DE
Germany
Prior art keywords
piperdino
alcohols
medicinal preparation
oral medicinal
solved form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69631132T
Other languages
English (en)
Other versions
DE69631132T2 (de
Inventor
T Ortyl
F Skultety
H Hurst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69631132D1 publication Critical patent/DE69631132D1/de
Publication of DE69631132T2 publication Critical patent/DE69631132T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
DE69631132T 1995-06-06 1996-04-30 Orales Arzneimittel von Piperidinoalkoholverbindungen in Lösungsform Expired - Lifetime DE69631132T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US469392 1995-06-06
US08/469,392 US5574045A (en) 1995-06-06 1995-06-06 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
PCT/US1996/005968 WO1996039139A1 (en) 1995-06-06 1996-04-30 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form

Publications (2)

Publication Number Publication Date
DE69631132D1 true DE69631132D1 (de) 2004-01-29
DE69631132T2 DE69631132T2 (de) 2004-08-19

Family

ID=23863607

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69631132T Expired - Lifetime DE69631132T2 (de) 1995-06-06 1996-04-30 Orales Arzneimittel von Piperidinoalkoholverbindungen in Lösungsform

Country Status (22)

Country Link
US (1) US5574045A (de)
EP (1) EP0831820B1 (de)
JP (1) JP4091655B2 (de)
KR (1) KR100509316B1 (de)
CN (1) CN1139386C (de)
AR (1) AR002191A1 (de)
AT (1) ATE256465T1 (de)
AU (1) AU707218B2 (de)
CA (1) CA2218643C (de)
DE (1) DE69631132T2 (de)
DK (1) DK0831820T3 (de)
ES (1) ES2211954T3 (de)
HU (1) HU227710B1 (de)
IL (1) IL118525A (de)
MX (1) MX9709453A (de)
NO (1) NO318029B1 (de)
NZ (1) NZ307370A (de)
PT (1) PT831820E (de)
SI (1) SI0831820T1 (de)
TW (1) TW460283B (de)
WO (1) WO1996039139A1 (de)
ZA (1) ZA964517B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
ES2176329T3 (es) * 1994-05-18 2002-12-01 Aventis Pharma Inc Procedimientos para preparar formas anhidras e hidratadas de derivados antihistaminicos de piperidina, sus polimeros y pseudomorfos.
HUP9802086A3 (en) * 1995-02-28 2001-02-28 Aventis Pharmaceuticals Inc Br Pharmaceutical composition for piperidinoalkanol compounds
ES2107375B1 (es) * 1995-08-01 1998-07-01 Almirall Prodesfarma Sa Formulaciones farmaceuticas liquidas de ebastina por via oral.
US6451815B1 (en) 1997-08-14 2002-09-17 Aventis Pharmaceuticals Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
CN1159012C (zh) * 1997-08-26 2004-07-28 阿旺蒂斯制药公司 用于组合哌啶子基烷醇-减充血剂的药物组合物
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US6613906B1 (en) 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
US20060205752A1 (en) * 2005-03-14 2006-09-14 Keith Whitehead Stabilized hydrocodone pharmaceutical compositions with ethylenediaminetetraacetic acid

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3966949A (en) * 1973-10-12 1976-06-29 Richardson-Merrell Inc. Pharmaceutical compositions and preparing same
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
EP0111114A3 (de) * 1982-11-06 1985-10-09 Telefonbau und Normalzeit GmbH Schaltungsanordnung für eine Fernsprechvermittlungsanlage, insbesondere Fernsprechnebenstellenanlage mit zusätzlichem Datenverkehr
DK164642C (da) * 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
AR245888A1 (es) * 1989-01-23 1994-03-30 Merrell Pharma Inc Procedimiento para la preparacion de una composicion farmaceutica liquida de derivados de piperidinoalcanol.
US4966061A (en) * 1989-03-27 1990-10-30 Riera John F Tube cutting apparatus

Also Published As

Publication number Publication date
NO975680L (no) 1998-02-05
CA2218643A1 (en) 1996-12-12
AU707218B2 (en) 1999-07-08
IL118525A (en) 2001-07-24
AR002191A1 (es) 1998-01-07
CA2218643C (en) 2001-12-11
DK0831820T3 (da) 2004-04-13
JP4091655B2 (ja) 2008-05-28
CN1139386C (zh) 2004-02-25
TW460283B (en) 2001-10-21
NO975680D0 (no) 1997-12-05
HUP9802096A2 (hu) 1999-01-28
WO1996039139A1 (en) 1996-12-12
MX9709453A (es) 1998-02-28
ZA964517B (en) 1996-12-09
KR19990022504A (ko) 1999-03-25
NO318029B1 (no) 2005-01-24
ATE256465T1 (de) 2004-01-15
NZ307370A (en) 1999-07-29
IL118525A0 (en) 1996-10-16
US5574045A (en) 1996-11-12
DE69631132T2 (de) 2004-08-19
JPH11506115A (ja) 1999-06-02
KR100509316B1 (ko) 2005-11-25
ES2211954T3 (es) 2004-07-16
PT831820E (pt) 2004-05-31
AU5669596A (en) 1996-12-24
EP0831820A1 (de) 1998-04-01
EP0831820B1 (de) 2003-12-17
SI0831820T1 (en) 2004-04-30
HU227710B1 (en) 2011-12-28
HUP9802096A3 (en) 1999-06-28
CN1187125A (zh) 1998-07-08

Similar Documents

Publication Publication Date Title
ATE206924T1 (de) Oral anzuwendende arzneizubereitung enthaltend olanzapin
ATE219377T1 (de) Neue galenische orale pharmazeutische formulierung
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
DE69525148D1 (de) Pharmazeutische formulierung
NO981008D0 (no) Farmasöytisk formulering
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
TR199600499A2 (tr) S(+)-Etodolak'in oral formülasyonlari.
BR9610983A (pt) Formas estáveis de administração farmacêuticas contendo paratormônio
ATE186541T1 (de) Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung
DE69631132D1 (de) Orale arzneimittel zubereitung von piperdinoalkanole in gelöster form
ATE210976T1 (de) Arzneimittel bestehend aus diclofenac
DE69614407T2 (de) Pharmazeutische zusammensetzungen
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
FI973230A (fi) Uusi farmaseuttinen formulaatio
KR970001311A (ko) 에틸 아미도 플루오렌 유도체 및 이를 함유한 약제조성물
FI974376A (fi) Pneumokokkaalisten antigeenien annostelu suun kautta
DE69636254D1 (de) Bismut enthaltende arzneimittel in topischen darreichungsformen
KR970000226A (ko) S-이부프로펜의 경구용 제형
NO974458D0 (no) Fremstilling av cis-4-O-beskyttede-2-cyklopentenolderivater
DE69431154D1 (de) Arzneimittel zur topischen Anwendung
ATE332709T1 (de) Stabilisiertes arzneimittel enthaltend cysteinylderivate
ITMI941139A0 (it) Distributore di sostanze cremose in particolare di paste dentifricie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS HOLDINGS INC., GREENVILLE, DEL., US

8327 Change in the person/name/address of the patent owner

Owner name: AVENTISUB II INC., GREENVILLE, DEL., US